Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains? (Q36140353)

12 August 2017

Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains? (English)

1 reference

12 August 2017

0 references

1 reference

3

Manit Srisurapanont

1 reference

12 August 2017

1

Sirijit Suttajit

1 reference

12 August 2017

5

Ronnachai Kongsakon

1 reference

12 August 2017

Suwanna Arunpongpaisal

2

1 reference

12 August 2017

Nuntika Thavichachart

4

1 reference

12 August 2017

Sunanta Chantakarn

6

1 reference

12 August 2017

Vasu Chantarasak

7

1 reference

12 August 2017

Apichat Jariyavilas

8

1 reference

12 August 2017

Piyadit Jaroensook

9

1 reference

12 August 2017

Khanogwan Kittiwattanagul

10

1 reference

12 August 2017

Osot Nerapusee

11

1 reference

12 August 2017

language of work or name

English

0 references

publication date

29 September 2015

1 reference

Neuropsychiatric Disease and Treatment

12 August 2017

1 reference

12 August 2017

11

1 reference

12 August 2017

2471-2477

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

12 August 2017

start time

1 September 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Cognitive and symptomatic predictors of functional disability in schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Impairment, disability, social support and depression among older parents in rural Thailand

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

A review of instruments for measuring functional recovery in those diagnosed with psychosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Cross-cultural validation and inter-rater reliability of the Personal and Social Performance scale, Thai version.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Symptoms versus neurocognitive skills as correlates of everyday functioning in severe mental illness

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Defining and measuring clinical effectiveness in the treatment of schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

The positive and negative syndrome scale (PANSS) for schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Verbal fluency and psychiatric symptoms in geriatric schizophrenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

The psychopathological characteristics of treatment discontinuation group in 6-month treatment with paliperidone ER.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Clinical characteristics influencing age at onset in psychotic disorders

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Is lack of insight associated with physically aggressive behavior among people with schizophrenia living in the community?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

What does the PANSS mean?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Psychosocial functioning on the Independent Living Skills Survey in older outpatients with schizophrenia

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4599141

The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study

23 September 2018

1 reference

12 December 2020

Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study

1 reference

12 December 2020

Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia

1 reference

12 December 2020

The functional significance of symptomatology and cognitive function in schizophrenia

1 reference

12 December 2020

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1 reference

12 December 2020

Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis

1 reference

12 December 2020

Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up

1 reference

12 December 2020

Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up

1 reference

12 December 2020

Identifiers

DOI

10.2147/NDT.S88085

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26491325

1 reference